Overexpression of glycogen phosphorylase increases GLUT4 expression and glucose transport in cultured skeletal human muscle. 1998

S Baqué, and E Montell, and M Camps, and J J Guinovart, and A Zorzano, and A M Gómez-Foix
Department de Bioquímica i Biologia Molecular, Universitat de Barcelona, Spain.

Skeletal muscle glucose utilization, a major factor in the control of whole-body glucose tolerance, is modulated in accordance with the muscle metabolic demand. For instance, it is increased in chronic contraction or exercise training in association with elevated expression of GLUT4 and hexokinase II (HK-II). In this work, the contribution of increased metabolic flux to the regulation of the glucose transport capacity was analyzed in cultured human skeletal muscle engineered to overexpress glycogen phosphorylase (GP). Myocytes treated with an adenovirus-bearing muscle GP cDNA (AdCMV-MGP) expressed 10 times higher GP activity and exhibited a twofold increase in the Vmax for 2-deoxy-D-[3H]glucose (2-DG) uptake, with no effect on the apparent Km. The stimulatory effect of insulin on 2-DG uptake was also markedly enhanced in AdCMV-MGP-treated cells, which showed maximal insulin stimulation 2.8 times higher than control cells. No changes in HKII total activity or the intracellular compartmentalization were found. GLUT4, protein, and mRNA were raised in AdCMV-MGP-treated cells, suggesting pretranslational activation. GLUT4 was immunodetected intracellularly with a perinuclear predominance. Culture in glucose-free or high-glucose medium did not alter GLUT4 protein content in either control cells or AdCMV-MGP-treated cells. Control and GP-overexpressing cells showed similar autoinhibition of glucose transport, although they appeared to differ in the mechanism(s) involved in this effect. Whereas GLUT1 protein increased in control cells when they were switched from a high-glucose to a glucose-free medium, GLUT1 remained unaltered in GP-expressing cells upon glucose deprivation. Therefore, the increased intracellular metabolic (glycogenolytic-glycolytic) flux that occurs in muscle cells overexpressing GP causes an increase in GLUT4 expression and enhances basal and insulin-stimulated glucose transport, without significant changes in the autoinhibition of glucose transport. This mechanism of regulation may be operative in the postexercise situation in which GLUT4 expression is upregulated in coordination with increased glycolytic flux and energy demand.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D009004 Monosaccharide Transport Proteins A large group of membrane transport proteins that shuttle MONOSACCHARIDES across CELL MEMBRANES. Hexose Transport Proteins,Band 4.5 Preactin,Erythrocyte Band 4.5 Protein,Glucose Transport-Inducing Protein,Hexose Transporter,4.5 Preactin, Band,Glucose Transport Inducing Protein,Preactin, Band 4.5,Proteins, Monosaccharide Transport,Transport Proteins, Hexose,Transport Proteins, Monosaccharide,Transport-Inducing Protein, Glucose
D009124 Muscle Proteins The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN. Muscle Protein,Protein, Muscle,Proteins, Muscle
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006005 Phosphorylases A class of glucosyltransferases that catalyzes the degradation of storage polysaccharides, such as glucose polymers, by phosphorolysis in animals (GLYCOGEN PHOSPHORYLASE) and in plants (STARCH PHOSPHORYLASE). Glucan Phosphorylase,Phosphorylase,alpha-Glucan Phosphorylases
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D051275 Glucose Transporter Type 4 A glucose transport protein found in mature MUSCLE CELLS and ADIPOCYTES. It promotes transport of glucose from the BLOOD into target TISSUES. The inactive form of the protein is localized in CYTOPLASMIC VESICLES. In response to INSULIN, it is translocated to the PLASMA MEMBRANE where it facilitates glucose uptake. GLUT-4 Protein,GLUT4 Protein,Insulin-Responsive Glucose Transporter,SLC2A4 Protein,Solute Carrier Family 2, Facilitated Glucose Transporter, Member 4 Protein,GLUT 4 Protein,Glucose Transporter, Insulin-Responsive,Insulin Responsive Glucose Transporter

Related Publications

S Baqué, and E Montell, and M Camps, and J J Guinovart, and A Zorzano, and A M Gómez-Foix
February 1996, The Journal of biological chemistry,
S Baqué, and E Montell, and M Camps, and J J Guinovart, and A Zorzano, and A M Gómez-Foix
January 2005, Acta physiologica Scandinavica,
S Baqué, and E Montell, and M Camps, and J J Guinovart, and A Zorzano, and A M Gómez-Foix
May 1994, The Journal of biological chemistry,
S Baqué, and E Montell, and M Camps, and J J Guinovart, and A Zorzano, and A M Gómez-Foix
January 2004, Pflugers Archiv : European journal of physiology,
S Baqué, and E Montell, and M Camps, and J J Guinovart, and A Zorzano, and A M Gómez-Foix
October 1994, Diabetes,
S Baqué, and E Montell, and M Camps, and J J Guinovart, and A Zorzano, and A M Gómez-Foix
February 1997, Biochemical Society transactions,
S Baqué, and E Montell, and M Camps, and J J Guinovart, and A Zorzano, and A M Gómez-Foix
January 1996, The Biochemical journal,
S Baqué, and E Montell, and M Camps, and J J Guinovart, and A Zorzano, and A M Gómez-Foix
January 2005, Diabetologia,
S Baqué, and E Montell, and M Camps, and J J Guinovart, and A Zorzano, and A M Gómez-Foix
September 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
S Baqué, and E Montell, and M Camps, and J J Guinovart, and A Zorzano, and A M Gómez-Foix
January 1983, Acta physiologica Scandinavica. Supplementum,
Copied contents to your clipboard!